Microscopically positive margins for primary gastrointestinal stromal tumors: Analysis of risk factors and tumor recurrence

Journal of the American College of Surgeons

Volumn 215, Issue 1, 2012, Pages 53-59

  McCarter, Martin D ^a   Antonescu, Cristina R ^b   Ballman, Karla V ^d   Maki, Robert G ^c   Pisters, Peter W T ^e   Demetri, George D ^f   Blanke, Charles D ^g   Von Mehren, Margaret ^h   Brennan, Murray F ^b   McCall, Linda ⁱ   Ota, David M ^j   DeMatteo, Ronald P ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h FOX CHASE CANCER CENTER   (United States)

ⁱ DUKE CANCER INSTITUTE   (United States)

^j DUKE CLINICAL RESEARCH INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB;

ADULT; AGED; ARTICLE; BLEEDING; COLORECTAL TUMOR; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MITOSIS RATE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RISK ASSESSMENT; RUPTURE; SMALL INTESTINE TUMOR; STOMACH TUMOR; SURGICAL PATIENT; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR RUPTURE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PIPERAZINES; PYRIMIDINES; RISK FACTORS; YOUNG ADULT;

EID: 84862988334     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2012.05.008     Document Type: Article

References (22)

1. Rowell NP. Are mastectomy resection margins of clinical relevance? A systematic review. Breast 2010;19:14-22.
2. Ly QP, Sasson AR. Modern surgical considerations for gastric cancer. J Natl Compr Canc Netw 2008;6:885-894.
3. Wasserberg N, Gutman H. Resection margins in modern rectal cancer surgery. J Surg Oncol 2008;98:611-615.
4. Pisters PWT, Leung DHY, Woodruff J, et al. Analysis of prognostic factors in 1041 patients with localized soft tissue sarcoma of the extremity. J Clin Oncol 1996;14:1679-1689. (Pubitemid 26134227)
5. Trovik CS; Scanadinavian Sarcoma Group Project. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project. Acta Orthop Scand Suppl 2001;72:1-31.
6. Stojadinovic A, Leung DH, Hoos A, et al. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg 2002;235:424-434. (Pubitemid 34183894)
7. Langer C, Gunawan B, Schüler P, et al. Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours. Br J Surg 2003;90:332-339. (Pubitemid 36324113)
8. Ahmed I, Welch NT, Parsons SL. Gastrointestinal stromal tumours (GIST) - 17 years experience from Mid Trent Region (United Kingdom). Eur J Surg Oncol 2008;34:445-449. (Pubitemid 351381282)
9. Hinz S, Pauser U, Egberts JH, et al. Audit of a series of 40 gastrointestinal stromal tumour cases. Eur J Surg Oncol 2006;32:1125-1129. (Pubitemid 44774398)
10. Everett M, Gutman H. Surgical management of gastrointestinal stromal tumors: analysis of outcome with respect to surgical margins and technique. J Surg Oncol 2008;98:588-593.
11. DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51-58. (Pubitemid 30043939)
12. Gouveia AM, Pimenta AP, Capelinha AF, et al. Surgical margin status and prognosis of gastrointestinal stromal tumor. World J Surg 2008;32:2375-2382.
13. Dematteo RP, Ballman KV, Antonescu CR, et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet 2009;373:1097-1104.
14. Pierie JP, Choudry U, Muzikansky A, et al. The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 2001;136:383-389. (Pubitemid 32322809)
15. McGrath PC, Neifeld JP, Lawrence W Jr, et al. Gastrointestinal sarcomas. Analysis of prognostic factors. Ann Surg 1987;206:706-710. (Pubitemid 18056185)
16. Crosby JA, Catton CN, Davis A, et al. Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. Ann Surg Oncol 2001;8:50-59. (Pubitemid 32140424)
17. Hassan I, You YN, Shyyan R, et al. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Ann Surg Oncol 2008;15:52-59.
18. Bucher P, Egger JF, Gervaz P, et al. An audit of surgical management of gastrointestinal stromal tumours (GIST). Eur J Surg Oncol 2006;32:310-314.
19. Unalp HR, Derici H, Kamer E, et al. Gastrointestinal stromal tumours: outcomes of surgical management and analysis of prognostic variables. Can J Surg 2009;52:31-38.
20. Keun Park C, Lee EJ, Kim M, et al. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy. Ann Surg 2008;247:1011-1018. (Pubitemid 351770422)
21. Lin SC, Huang MJ, Zeng CY, et al. Clinical manifestations and prognostic factors in patients with gastrointestinal stromal tumors. World J Gastroenterol 2003;9:2809-2812.
22. Demetri GD, von Mehren M, Antonescu CR, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw 2010;8 Suppl 2:S1-41.